BridgeBio Pharma (BBIO) Insider Trading & Ownership $39.03 +0.41 (+1.06%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$39.20 +0.17 (+0.45%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$693.17M Get BBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BBIO Insider Buying and Selling by Quarter BridgeBio Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/20/2025Neil KumarCEOSell75,000$33.40$2,505,000.00 5/19/2025Neil KumarCEOSell26,156$33.33$871,779.48 5/12/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$34.20$205,200,000.00 5/2/2025Andrew LoDirectorSell100,000$38.50$3,850,000.00 5/2/2025Maricel ApuliCAOSell1,026$38.51$39,511.26 4/22/2025Neil KumarCEOSell75,000$34.11$2,558,250.00 4/14/2025Andrea EllisDirectorSell10,000$35.00$350,000.00 4/1/2025Andrea EllisDirectorSell30,000$34.05$1,021,500.00 3/25/2025Neil KumarCEOSell75,000$36.87$2,765,250.00 3/5/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$32.96$197,760,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/25/2025Brian C StephensonCFOSell8,500$33.19$282,115.00 2/25/2025Neil KumarCEOSell75,000$33.57$2,517,750.00 2/19/2025Brian C StephensonCFOSell4,148$36.16$149,991.68 2/19/2025Neil KumarCEOSell31,543$36.14$1,139,964.02 1/31/2025Global Investors Lp VikingMajor ShareholderSell3,065,616$34.90$106,989,998.40 1/28/2025Brian C StephensonCFOSell68,000$36.29$2,467,720.00 1/28/2025Neil KumarCEOSell326,932$36.29$11,864,362.28 11/19/2024Brian C StephensonCFOSell4,156$22.41$93,135.96 11/19/2024Neil KumarCEOSell27,389$22.41$613,787.49 9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.00 8/19/2024Brian C StephensonCFOSell4,155$24.69$102,586.95 8/19/2024Neil KumarCEOSell27,389$24.69$676,234.41 (Data available from 1/1/2013 forward) BBIO Insider Trading Activity - Frequently Asked Questions Who is on BridgeBio Pharma's Insider Roster? The list of insiders at BridgeBio Pharma includes Andrea Ellis, Andrew Lo, Brian C Stephenson, Frank Mccormick, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Hannah Valantine, Maricel Apuli, Neil Kumar, and Randal W Scott. Learn more on insiders at BBIO. What percentage of BridgeBio Pharma stock is owned by insiders? 18.20% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings. Which BridgeBio Pharma insiders have been selling company stock? The following insiders have sold BBIO shares in the last 24 months: Andrea Ellis ($1,371,500.00), Andrew Lo ($3,850,000.00), Brian C Stephenson ($3,744,056.56), Frank Mccormick ($4,206,000.00), Genetic Disorder L.P. Kkr ($552,310,000.00), Global Investors Lp Viking ($159,489,998.40), Hannah Valantine ($110,682.55), Maricel Apuli ($39,511.26), Neil Kumar ($26,986,249.36), and Randal W Scott ($193,840.00). How much insider selling is happening at BridgeBio Pharma? Insiders have sold a total of 23,517,660 BridgeBio Pharma shares in the last 24 months for a total of $752,301,838.13 sold. BridgeBio Pharma Key ExecutivesDr. Neil Kumar Ph.D. (Age 45)Co-Founder, President, CEO & Director Compensation: $1.53MDr. Charles J. Homcy M.D. (Age 76)Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director Compensation: $563.2kDr. Frank P. McCormick Ph.D. (Age 74)Co-Founder, Chairman of Oncology & Director Compensation: $542.78kDr. Brian C. Stephenson C.F.A. (Age 43)Ph.D., CFO & Secretary Compensation: $1.15MDr. Richard H. Scheller Ph.D. (Age 71)Chairman of Research & Development Compensation: $509.62kDr. Uma Sinha Ph.D. (Age 66)Chief Scientific Officer Compensation: $1.31MGrace RauhVice President of CommunicationsMr. Eli M. Wallace Ph.D. (Age 57)Chief Scientific Officer of Oncology Dr. Thomas Trimarchi Ph.D.Chief Product OfficerDr. Eric Michael David J.D. (Age 52)M.D., Ph.D., Chief Executive Officer of Gene Therapy More Insider Trading Tools from MarketBeat Related Companies Beigene Insider Selling Teva Pharmaceutical Industries Insider Selling Intra-Cellular Therapies Insider Selling Genmab A/S Insider Selling Summit Therapeutics Insider Selling Moderna Insider Selling Viatris Insider Selling Blueprint Medicines Insider Selling Roivant Sciences Insider Selling Revolution Medicines Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short Squeezes3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip? This page (NASDAQ:BBIO) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredTrump’s treachery This might just be the greatest time in America to be an energy company. Since taking office in 2025, Presi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
